NCT07138391

Brief Summary

The aim of this study is to evaluate the effect of oral chamomile on reducing dental anxiety in children. Anxiety assessments will be done by recording the pulse rate and blood pressure and by using modified child dental anxiety scale.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
78

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Aug 2025

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 5, 2025

Completed
27 days until next milestone

Study Start

First participant enrolled

August 1, 2025

Completed
21 days until next milestone

First Posted

Study publicly available on registry

August 22, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2025

Completed
Last Updated

August 22, 2025

Status Verified

June 1, 2025

Enrollment Period

2 months

First QC Date

July 5, 2025

Last Update Submit

August 21, 2025

Conditions

Keywords

dental anxietychamomilechildren

Outcome Measures

Primary Outcomes (3)

  • Assessment of anxiety

    Anxiety assessments will be done using: 1\) The pulse rate: Pulse rate will be measured using a finger-base type pulse oximeter (Beurer, Ulm, Germany). The children will be asked not to move their hand while the finger pulse oximeter is attached to their left index finger.

    1st measurement before gummy chewing and swallowing 2nd measurement 30 mins after gummy swallowing 3rd measurement after local anesthesia injection 4th measurement after completion of dental work one dental visit

  • Assessment of anxiety

    Anxiety assessments will be done using: 2\) Blood pressure: this will be measured using a digital blood pressure scale.

    1st measurement before gummy chewing and swallowing 2nd measurement 30 mins after gummy swallowing 3rd measurement after local anesthesia injection 4th measurement after completion of dental work one dental visit

  • Assessment of anxiety

    Anxiety assessments will be done using: 3\) Modified Child Dental Anxiety Scale:

    1st measurement before gummy chewing and swallowing 2nd measurement 30 mins after gummy swallowing 3rd measurement after local anesthesia injection 4th measurement after completion of dental work one dental visit

Study Arms (2)

intervention group

EXPERIMENTAL

Participants in the intervention group will receive one chamomile gummy to chew approximately 30 minutes prior to their dental appointment. The gummy used in this study was Zarbee's Gentle Bedtime Gummies for Kids (Zarbee's Inc., USA).

Drug: chamomile gummy

The control group

PLACEBO COMPARATOR

The control group will receive a multivitamin gummy, as a placebo, administered at the same time point (30 minutes prior to the appointment)

Dietary Supplement: a multivitamin gummy

Interventions

The chamomile gummy used in this study was Zarbee's Gentle Bedtime Gummies for Kids (Zarbee's Inc., USA).

intervention group
a multivitamin gummyDIETARY_SUPPLEMENT

multivitamins gummies for kids

The control group

Eligibility Criteria

Age5 Years - 8 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Patients exhibiting Frankl's behavior rating grade III or IV.
  • Children requiring invasive dental treatment in their primary teeth

You may not qualify if:

  • Patients with severe dental symptoms (e.g. spontaneous pain, pain not relieved by analgesics).
  • History of allergy to local anesthesia
  • Children who currently use any medication

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ain-shams university

Cairo, Egypt

Location

Central Study Contacts

Basma M Nagi, lecturer

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 5, 2025

First Posted

August 22, 2025

Study Start

August 1, 2025

Primary Completion

October 1, 2025

Study Completion

November 1, 2025

Last Updated

August 22, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations